Persistent paroxysmal tachycardia eventually produces cardiac failure and threatens the patient's life. Quinidine, which acts by depressing cardiac muscle and increasing the refractory period, is frequently successful in restoring the cardiac rhythm in such cases.
It is usually administered orally. Intravenous administration is occasionally used in cases of extreme urgency but this method of administration is not free from toxic effects and sudden death has followed its use.
Other drugs with a quinidine-like action have recently become available. Dawes (1946) demonstrated experimentally that procaine hydrochloride had a quinidine-like action on cardiac muscle equal in potency to that of quinidine itself. Procaine hydrochloride has been used to reduce cardiac irritability and arrhythmias occurring in the course of thoracic and cardiac surgery. However, the use of procaine hydrochloride for its cardiac action is limited by the fact that it is rapidly broken down by the procaine esterase of the blood and liver into p-amino benzoic acid and diethylaminoethanol. Its direct-writing electrocardiograph was used to observe the effect of the drug on the cardiac activity. The tracing on this instrument is recorded at double the conventional speed, and the preliminary control tracing (Fig. 2) (Irvin & Cutts, 1951 (Fig. 4) in which we used intravenous procaine amide unsuccessfully, widening of the QRS complex and ventricular extra systoles were induced after 0.7 g. of the drug had been given (Fig. 5) Procaine amide intravenously appears to be a useful additional drug m the treatment of paroxysmal tachycardia and, given orally, may be of value as a preventative in patients subject to frequent attacks of this disorder.
SUMMARY.
A case of paroxysmal supraventricular tachycardia is described which was resistant to oral quinidine therapy and other standard measures.
The tachycardia was finally controlled by the intravenous administration of procaine amide. The dosage and methods of administration of procaine amide are discussed.
The use of a direct-writing electrocardiograph is advised to control its intravenous administration.
